Amgen(US:AMGN) Prnewswire·2026-01-07 21:01Core Viewpoint - Amgen will present at the 2026 J.P. Morgan Healthcare Conference, highlighting its ongoing commitment to innovation and investor engagement [1]. Group 1: Conference Details - The presentation will take place on January 12, 2026, at 3:45 p.m. PT, led by Robert A. Bradway, the chairman and CEO of Amgen [1]. - The webcast will be available for media, investors, and the general public, and will be archived for at least 90 days post-event [2]. Group 2: Company Overview - Amgen is a leader in biotechnology, focusing on discovering, developing, manufacturing, and delivering innovative medicines for serious diseases [3]. - The company has a robust pipeline aimed at treating cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [3]. Group 3: Recognition and Market Position - In 2024, Amgen received accolades such as being named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes [4]. - Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100 Index, reflecting its significant market capitalization and innovation [4].